Maria Sharapova is expected to file an appeal of her recent 2 year suspension by the International Tennis Federation. She tested positive for meldonium at the Australian Open.
The five-time Grand Slam champion was provisionally suspended by the ITF in early March, when she announced at a news conference in Los Angeles that she failed a doping test in January.
Sharapova said then she was not aware that the World Anti-Doping Agency had barred athletes from using meldonium, also known as mildronate, as of Jan. 1.
Her lawyer, John Haggerty, says Sharapova took the substance after that date.
Sharapova said she first was prescribed the Latvian-made drug, typically used for heart conditions, for medical reasons in 2006.
This post has been seen 331 times.